TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
4.050
-0.070 (-1.69%)
Nov 21, 2024, 1:03 PM EST - Market open

TScan Therapeutics Revenue

TScan Therapeutics had revenue of $1.05M in the quarter ending September 30, 2024, a decrease of -73.01%. This brings the company's revenue in the last twelve months to $9.36M, down -44.71% year-over-year. In the year 2023, TScan Therapeutics had annual revenue of $21.05M with 55.52% growth.

Revenue (ttm)
$9.36M
Revenue Growth
-44.71%
P/S Ratio
23.48
Revenue / Employee
$60,792
Employees
154
Market Cap
216.15M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202321.05M7.51M55.52%
Dec 31, 202213.54M3.39M33.47%
Dec 31, 202110.14M9.06M834.65%
Dec 31, 20201.09M--
Dec 31, 2019---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
High Tide 370.02M
Inogen 331.52M
biote 193.06M
Sutro Biopharma 160.96M
Genfit 86.23M
Utah Medical Products 44.08M
Zentalis Pharmaceuticals 40.56M
aTyr Pharma 235.00K
Revenue Rankings